Neumora Therapeutics Begins U.S. IPO Rollout (Pending:NMRA)

Female Scientist Looking Under Microscope And Using Laptop In A Laboratory


A Quick Take On Neumora Therapeutics

Neumora Therapeutics, Inc. (NMRA) as filed to raise $100 million in an IPO of its common stock, according to an SEC S-1 registration statement.

The company is a clinical-stage biopharma developing drug

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *